Tele-Palliative Care for Graft-versus-Host Disease (cGVHDTele-PC Trial)

N/A

Waitlist Available

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Patients who have already consulted or are currently consulting palliative care

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 12

Awards & highlights

No Placebo-Only Group

Summary

This trial is looking at whether using telehealth for palliative care is a practical and acceptable option for patients with moderate to severe chronic graft-versus-host disease.

Who is the study for?

This trial is for adults over 18 with moderate to severe chronic graft-versus-host disease (cGVHD) as assessed by their oncologist. Participants must understand and speak English well enough to answer questions. Those with acute psychiatric or cognitive conditions, or who are already in palliative care, cannot join.

What is being tested?

The study is testing the use of telehealth for providing palliative care to patients suffering from cGVHD. It aims to determine how practical and acceptable it is for patients to receive this type of remote healthcare service.

What are the potential side effects?

Since the intervention involves tele-palliative care visits rather than medication, traditional side effects are not expected. However, participants may experience emotional discomfort discussing their condition remotely.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am currently receiving or have received palliative care.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Feasibility of the tele-palliative care intervention as measured by the proportion of eligible patients who are approached and agree to participate

Feasibility of the tele-palliative care intervention as measured by the proportion of enrolled participants who complete at least two of the three intervention visits

Secondary study objectives

Acceptability of the tele-palliative care intervention as measured by the Client Satisfaction Questionnaire

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Tele-PC InterventionExperimental Treatment1 Intervention

Participants (individuals with moderate to severe chronic Graft-versus-Host Disease) will receive a monthly at home consultation with a specialty palliative care clinician via a video-conference tele-health visit.

0 / 1Eligibility criteria met